New study demonstrates LINX® safety and efficacy rivals laparoscopic
Nissen fundoplication. Study authors conclude LINX is as effective as
Nissen in controlling reflux, with fewer side effects.
Torax Medical, Inc. announced today the release of new data from the University of Southern California's Keck Medicine, a leading institution in the diagnosis and treatment of gastro-esophageal reflux disease (GERD). The retrospective study, led by Dr. John C. Lipham, compared the LINX® Reflux Management System (LINX) to the standard of care of Laparoscopic Nissen Fundoplication (LNF) in similar patient populations.
Download the PDF below for the complete PR release.